NCT05106868

Brief Summary

Several studies investigating acupuncture for major depressive disorder (MDD) have been carried out. However, investigators found the results were in high heterogeneity and poor methodological quality. Thus, investigators intend to provide high quality of the effectiveness and safety of acupuncture for MDD.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
123

participants targeted

Target at P75+ for not_applicable major-depressive-disorder

Timeline
Completed

Started Nov 2021

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 25, 2021

Completed
7 days until next milestone

Study Start

First participant enrolled

November 1, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 4, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

November 4, 2021

Status Verified

October 1, 2021

Enrollment Period

1.2 years

First QC Date

October 25, 2021

Last Update Submit

October 25, 2021

Conditions

Keywords

acupuncturemajor depressive disorderrandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • score of Hamilton Depression Rating Scale-24

    Reduction in the severity of depression, measured at the end of the intervention primarily as a continuous variable on the Hamilton Depression Rating Scale (HAMD)-24

    change from baseline to 4 weeks after intervention, after follow-up(4 week)

Secondary Outcomes (11)

  • score of self-rating depression scale

    baseline, after intervention(4 week), after follow-up(4 week)

  • score of Hamilton Anxiety Rating Scale

    baseline, after intervention(4 week) , after follow-up(4 week)

  • score of Social Disability Screening Schedule

    baseline, after intervention(4 week) , after follow-up(4 week)

  • score of Pittsburgh sleep quality index (PSQI)

    baseline, after intervention(4 week) , after follow-up(4 week)

  • motor threshold (MT)

    baseline, after intervention(4 week) , after follow-up(4 week)

  • +6 more secondary outcomes

Study Arms (3)

acupuncture

EXPERIMENTAL

5 sessions of acupuncture per week for 4 weeks. In each session, acupuncture will be applied bilaterally on acupoints. We will use transcutaneous electric acupoints stimulation (HANS; Han's acupoints nerve stimulator, HANS-200, Nanjing, China) to stimulate the acupoints. Each session will last 30 minutes.

Device: acupuncture

sham acupuncture

SHAM COMPARATOR

5 sessions of sham acupuncture per week for 4 weeks. In each session, acupuncture will be applied bilaterally on non-acupoints. We will use transcutaneous electric acupoints stimulation (HANS; Han's acupoints nerve stimulator, HANS-200, Nanjing, China) to stimulate the non-acupoints. Each session will last 30 minutes.

Device: acupuncture

waiting-list

NO INTERVENTION

Interventions

Acupuncture is a form of alternative medicine and a component of traditional Chinese medicine (TCM) in which thin needles are inserted into the acupoints on body to treat diseases.

acupuncturesham acupuncture

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Right-handed participants aged between 18 to 60 years;
  • participants diagnosed with mild to moderate major depressive disorder(MDD), and meet the diagnostic criteria of mild to moderate MDD according to the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition (DSM-5);
  • participants with score of HAMD-24 between 8 to 35;
  • participants without anti-depressive medication more than 3 months;
  • participants willing to comply with the study protocol;
  • participants willing to sign informed consent form.

You may not qualify if:

  • participants with severe medical visceral condition and chronic diseases, such as hypertension, coronary heart disease, hyperthyroidism, hypothyroidism or diabetes and other endocrine system diseases;
  • participants with brain organic diseases: such as birth injury, trauma, encephalitis, tumor, etc.;
  • participants with Peripheral nerve and muscular system diseases;
  • participants with severe anxiety, obsessive-compulsive disorder, or a history of mania or hypomania;
  • Recently taken drugs that may cause mood disorders;
  • Severe bleeding tendency, allergic constitution and skin disease patients;
  • pregnant or lactation women;
  • Persons with visual and hearing disabilities;
  • Participants with pacemakers, deep brain stimulators, vagus nerve stimulators, metal internal fixators, etc
  • participate in other clinical trials at the same time

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Depressive Disorder, Major

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Jian Huang

    Institute of Science and Technology Development, Sichuan University

    STUDY CHAIR

Central Study Contacts

Zhong Zheng, PhD

CONTACT

Rongjiang Jin

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 25, 2021

First Posted

November 4, 2021

Study Start

November 1, 2021

Primary Completion

December 30, 2022

Study Completion

June 30, 2023

Last Updated

November 4, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share